Insulin degludec Subcutaneous and Olodaterol and tiotropium
Determining the interaction of Insulin degludec Subcutaneous and Olodaterol and tiotropium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: olodaterol / tiotropium
Brand name: Stiolto Respimat 28 ACT, Stiolto Respimat 60 ACT, Stiolto Respimat 10 ACT, Stiolto Respimat
Synonyms: Tiotropium and Olodaterol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Olodaterol Hydrochloride
- Insulin degludec Subcutaneous-Olodaterol inhalation
- Insulin degludec Subcutaneous-Olopatadine nasal
- Insulin degludec Subcutaneous-Olopatadine Nasal Spray
- Insulin degludec Subcutaneous-Olsalazine
- Insulin degludec Subcutaneous-Olsalazine Sodium
- Olodaterol and tiotropium-Insulin detemir
- Olodaterol and tiotropium-Insulin Detemir (Cartridges and Prefilled Syringes)
- Olodaterol and tiotropium-Insulin Detemir (Vials)
- Olodaterol and tiotropium-Insulin detemir Subcutaneous
- Olodaterol and tiotropium-Insulin glargine
- Olodaterol and tiotropium-Insulin Glargine (U-100) Cartridge Systems and Pens